Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$371,112
in 2 filings, $371K under 10b5-1 plans

Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gheuens Sarah −$371K Chief Medical Officer sold 15% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-02-27 NELSEN ROBERT Director Sale −53,985 $48.36 $2.6M 229,696
2017-02-27 NELSEN ROBERT Director Sale −83,750 $49.13 $4.1M 145,946
2017-02-27 NELSEN ROBERT Director Sale −57,488 $50.28 $2.9M 88,458
2017-02-23 NELSEN ROBERT Director Sale −42,596 $47.73 $2.0M 292,081
2017-02-23 NELSEN ROBERT Director Sale −8,400 $48.75 $409K 283,681
2017-02-22 NELSEN ROBERT Director Sale −46,938 $49.90 $2.3M 335,677
2017-02-22 NELSEN ROBERT Director Sale −1,000 $50.35 $50K 334,677
2017-02-21 Schenkein David P Chief Executive Officer Grant or award · Stock option (right to buy) +142,900 142,900
2017-02-21 Hoerter Steven L. Chief Commercial Officer Grant or award · Stock option (right to buy) +47,600 47,600
2017-02-21 Hirsch Andrew Chief Financial Officer Grant or award · Stock option (right to buy) +47,600 47,600
2017-02-21 Bowden Christopher Chief Medical Officer Grant or award · Stock option (right to buy) +47,600 47,600
2017-02-21 Biller Scott Chief Scientific Officer Grant or award · Stock option (right to buy) +47,600 47,600
2017-02-21 Alenson Carman Principal Accounting Officer Grant or award · Restricted stock units +3,300 3,300
2017-02-21 NELSEN ROBERT Director Sale −1,780 $54.17 $96K 417,265
2017-02-21 NELSEN ROBERT Director Sale −34,650 $50.56 $1.8M 382,615
2017-02-16 Schenkein David P Chief Executive Officer Option exercise +6,000 $0.30 $2K 6,000
2017-02-16 Schenkein David P Chief Executive Officer Sale −6,000 $50.01 $300K 0
2017-02-16 Schenkein David P Chief Executive Officer Option exercise · Stock option (right to buy) −6,000 201,656
2017-01-26 Schenkein David P Chief Executive Officer Grant or award · Stock option (right to buy) +68,182 136,363
2017-01-26 Biller Scott Chief Scientific Officer Grant or award · Common stock (right to buy) +34,090 54,090

Page 78 of 80 · 1,590 trades